Schöls L - Search Results

1

Genetic variability in the dopamine system (dopamine receptor D4, catechol-O-methyltransferase) modulates neurophysiological responses to gains and losses.

Marco-Pallarés J, Cucurell D, Cunillera T, Krämer UM, Càmara E, Nager W, Bauer P, Schüle R, Schöls L, Münte TF, Rodriguez-Fornells A. Marco-Pallarés J, et al. Among authors: schols l. Biol Psychiatry. 2009 Jul 15;66(2):154-61. doi: 10.1016/j.biopsych.2009.01.006. Epub 2009 Feb 28. Biol Psychiatry. 2009. PMID: 19251248

2

Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17).

Rolfs A, Koeppen AH, Bauer I, Bauer P, Buhlmann S, Topka H, Schöls L, Riess O. Rolfs A, et al. Among authors: schols l. Ann Neurol. 2003 Sep;54(3):367-75. doi: 10.1002/ana.10676. Ann Neurol. 2003. PMID: 12953269

3

Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis.

Schöls L, Bauer P, Schmidt T, Schulte T, Riess O. Schöls L, et al. Lancet Neurol. 2004 May;3(5):291-304. doi: 10.1016/S1474-4422(04)00737-9. Lancet Neurol. 2004. PMID: 15099544 Review.

4

Spectrin mutations in spinocerebellar ataxia (SCA).

Bauer P, Schöls L, Riess O. Bauer P, et al. Among authors: schols l. Bioessays. 2006 Aug;28(8):785-7. doi: 10.1002/bies.20443. Bioessays. 2006. PMID: 16927298 Review.

5

Cerebrotendinous xanthomatosis.

Schöls L, Nägele T, Schüle R, Berg D. Schöls L, et al. Neurology. 2006 Dec 12;67(11):E20. doi: 10.1212/01.wnl.0000247673.08554.0f. Neurology. 2006. PMID: 17159091 No abstract available.

6

The impact of catechol-O-methyltransferase and dopamine D4 receptor genotypes on neurophysiological markers of performance monitoring.

Krämer UM, Cunillera T, Càmara E, Marco-Pallarés J, Cucurell D, Nager W, Bauer P, Schüle R, Schöls L, Rodriguez-Fornells A, Münte TF. Krämer UM, et al. Among authors: schols l. J Neurosci. 2007 Dec 19;27(51):14190-8. doi: 10.1523/JNEUROSCI.4229-07.2007. J Neurosci. 2007. PMID: 18094258 Free PMC article.

7

"Pseudodominant inheritance" of ataxia with ocular apraxia type 2 (AOA2).

Schöls L, Arning L, Schüle R, Epplen JT, Timmann D. Schöls L, et al. J Neurol. 2008 Apr;255(4):495-501. doi: 10.1007/s00415-008-0707-z. Epub 2008 Mar 20. J Neurol. 2008. PMID: 18350359

8

SCA3: neurological features, pathogenesis and animal models.

Riess O, Rüb U, Pastore A, Bauer P, Schöls L. Riess O, et al. Among authors: schols l. Cerebellum. 2008;7(2):125-37. doi: 10.1007/s12311-008-0013-4. Cerebellum. 2008. PMID: 18418689 Review.

9

Identification of a heterozygous genomic deletion in the spatacsin gene in SPG11 patients using high-resolution comparative genomic hybridization.

Bauer P, Winner B, Schüle R, Bauer C, Häfele V, Hehr U, Bonin M, Walter M, Karle K, Ringer TM, Riess O, Winkler J, Schöls L. Bauer P, et al. Among authors: schols l. Neurogenetics. 2009 Feb;10(1):43-8. doi: 10.1007/s10048-008-0144-2. Epub 2008 Sep 12. Neurogenetics. 2009. PMID: 18787847

10

Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis.

Schüle R, Siddique T, Deng HX, Yang Y, Donkervoort S, Hansson M, Madrid RE, Siddique N, Schöls L, Björkhem I. Schüle R, et al. Among authors: schols l. J Lipid Res. 2010 Apr;51(4):819-23. doi: 10.1194/jlr.M002543. Epub 2009 Oct 7. J Lipid Res. 2010. PMID: 19812052 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

508 results

Search Page